These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20399255)

  • 1. Effect of CFMTI, an allosteric metabotropic glutamate receptor 1 antagonist with antipsychotic activity, on Fos expression in regions of the brain related to schizophrenia.
    Suzuki G; Satow A; Ohta H
    Neuroscience; 2010 Jul; 168(3):787-96. PubMed ID: 20399255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique antipsychotic activities of the selective metabotropic glutamate receptor 1 allosteric antagonist 2-cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-2,3-dihydro-1H-isoindol-1-one.
    Satow A; Suzuki G; Maehara S; Hikichi H; Murai T; Murai T; Kawagoe-Takaki H; Hata M; Ito S; Ozaki S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2009 Jul; 330(1):179-90. PubMed ID: 19359526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
    Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity.
    Robertson GS; Matsumura H; Fibiger HC
    J Pharmacol Exp Ther; 1994 Nov; 271(2):1058-66. PubMed ID: 7965768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical properties of several classes of antipsychotic drugs on the basis of differential induction of Fos-like immunoreactivity in the rat brain.
    Oka T; Hamamura T; Lee Y; Miyata S; Habara T; Endo S; Taoka H; Kuroda S
    Life Sci; 2004 Nov; 76(2):225-37. PubMed ID: 15519367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological effects of metabotropic glutamate receptor ligands on prepulse inhibition in DBA/2J mice.
    Hikichi H; Nishino M; Fukushima M; Satow A; Maehara S; Kawamoto H; Ohta H
    Eur J Pharmacol; 2010 Aug; 639(1-3):99-105. PubMed ID: 20371235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acute and chronic administration of MK-801 on c-Fos protein expression in mice brain regions implicated in schizophrenia with or without clozapine.
    Zuo DY; Cao Y; Zhang L; Wang HF; Wu YL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):290-5. PubMed ID: 19121361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the antipsychotic drug mosapramine on the expression of Fos protein in the rat brain: comparison with haloperidol, clozapine and risperidone.
    Fujimura M; Hashimoto K; Yamagami K
    Life Sci; 2000 Oct; 67(23):2865-72. PubMed ID: 11106001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Widespread expression of Fos protein induced by acute haloperidol administration in the rat brain.
    Suzuki M; Sun YJ; Murata M; Kurachi M
    Psychiatry Clin Neurosci; 1998 Jun; 52(3):353-9. PubMed ID: 9681590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugs.
    Atkins JB; Chlan-Fourney J; Nye HE; Hiroi N; Carlezon WA; Nestler EJ
    Synapse; 1999 Aug; 33(2):118-28. PubMed ID: 10400890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of glycine transporter I inhibitor, N-methylglycine (sarcosine), on ketamine-induced alterations in sensorimotor gating and regional brain c-Fos expression in rats.
    Yang SY; Hong CJ; Huang YH; Tsai SJ
    Neurosci Lett; 2010 Jan; 469(1):127-30. PubMed ID: 19944746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic administration of haloperidol and clozapine induces differential effects on the expression of Arc and c-Fos in rat brain.
    Collins CM; Wood MD; Elliott JM
    J Psychopharmacol; 2014 Oct; 28(10):947-54. PubMed ID: 24989643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
    Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The brain pattern of c-fos induction by two doses of amphetamine suggests different brain processing pathways and minor contribution of behavioural traits.
    Rotllant D; Márquez C; Nadal R; Armario A
    Neuroscience; 2010 Jul; 168(3):691-705. PubMed ID: 20406670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities.
    Liu F; Grauer S; Kelley C; Navarra R; Graf R; Zhang G; Atkinson PJ; Popiolek M; Wantuch C; Khawaja X; Smith D; Olsen M; Kouranova E; Lai M; Pruthi F; Pulicicchio C; Day M; Gilbert A; Pausch MH; Brandon NJ; Beyer CE; Comery TA; Logue S; Rosenzweig-Lipson S; Marquis KL
    J Pharmacol Exp Ther; 2008 Dec; 327(3):827-39. PubMed ID: 18753411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain.
    Wan W; Ennulat DJ; Cohen BM
    Brain Res; 1995 Aug; 688(1-2):95-104. PubMed ID: 8542328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional classification of antidepressants based on antagonism of swim stress-induced fos-like immunoreactivity.
    Duncan GE; Knapp DJ; Johnson KB; Breese GR
    J Pharmacol Exp Ther; 1996 May; 277(2):1076-89. PubMed ID: 8627519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol.
    Pinna A; Wardas J; Cozzolino A; Morelli M
    Neuropsychopharmacology; 1999 Jan; 20(1):44-51. PubMed ID: 9885784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activation of orexin neurons by antipsychotic drugs associated with weight gain.
    Fadel J; Bubser M; Deutch AY
    J Neurosci; 2002 Aug; 22(15):6742-6. PubMed ID: 12151553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.